FBXO32 and sarcopenia: Chronic GC use is known to cause sarcopenia by stimulating muscle catabolic pathway11 and consistent to this finding, we observed decreased muscle mass due to reduced muscle size contributed by the upregulation of atrogin-1 and MurF-1, the proteins belonging to E3 ubiquitin ligase family.